Canada markets closed
  • S&P/TSX

    20,138.35
    +88.88 (+0.44%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • DOW

    34,479.60
    +13.36 (+0.04%)
     
  • CAD/USD

    0.8228
    -0.0041 (-0.50%)
     
  • CRUDE OIL

    70.78
    +0.49 (+0.70%)
     
  • BTC-CAD

    43,386.00
    -1,642.76 (-3.65%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • GOLD FUTURES

    1,879.50
    -16.90 (-0.89%)
     
  • RUSSELL 2000

    2,335.81
    +24.40 (+1.06%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • NASDAQ

    14,069.42
    +49.09 (+0.35%)
     
  • VOLATILITY

    15.65
    -0.45 (-2.80%)
     
  • FTSE

    7,134.06
    +45.88 (+0.65%)
     
  • NIKKEI 225

    28,948.73
    -9.83 (-0.03%)
     
  • CAD/EUR

    0.6792
    +0.0003 (+0.04%)
     

Tilray-Aphria deal closes, company to control biggest share of Cdn pot market

·1 min read

NANAIMO, B.C. — Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.

Tilray shareholders voted Friday in favour of issuing stock to Aphria's shareholders, but the Nanaimo, B.C.-based company has yet to reveal how many supported the proposal.

About 99 per cent of Aphria shareholders voted in favour of the deal in April.

The two cannabis companies announced in December that they will merge under the Tilray name with Aphria CEO Irwin Simon at the helm and Tilray CEO Brendan Kennedy joining the board.

The new company is expected to have a pro forma revenue of $874 million and will control more than 17 per cent of the retail cannabis market — the largest share held by any Canadian licensed producer.

While Tilray shareholders at Friday's meeting supported the Aphria deal, they voted against increasing the company's authorized capital stock from more than 743 million shares to 900 million shares.

This report by The Canadian Press was first published April 30, 2021.

Companies in this story: (TSX:APHA)

The Canadian Press